mode of action of glp 1 agonists Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1 Receptor Agonists in Gastrointestinal

1, rue du Perron CH 1204 Genve Tl

This approach could offer novel insights into the mechanisms by which IF exerts its effects, potentially leading to new therapeutic strategies for managing RA

A single order is designed to last 12 weeks

Important: Age Dermik contains Retinol, which increases sun sensitivity

Advantage: Convenient, familiar, non-invasive Challenge: Peptides face proteolytic degradation in the stomach and small intestine Bioavailability: Estimated at approximately 38% based on comparative pharmacology (see below) Transdermal (Patch) Some researchers have explored transdermal patches to deliver peptides: Advantage: Avoids first-pass metabolism and GI degradation Challenge: Intact skin is a strong barrier to peptide penetration Feasibility: Not commonly available commercially

Avoid topical antibiotic ointments unless prescribed, as overuse can cause resistance or irritation